Provided by Tiger Fintech (Singapore) Pte. Ltd.

ReShape Lifesciences, Inc.

2.57
+0.05402.14%
Volume:156.84K
Turnover:387.00K
Market Cap:6.14M
PE:-0.01
High:2.58
Open:2.42
Low:2.42
Close:2.52
Loading ...
Sep 12, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 26, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 16, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 26, 2023

Major Issues Report

8-K - Current report
Apr 17, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 13, 2023

Major Issues Report

8-K - Current report
Mar 21, 2023

Major Issues Report

8-K - Current report
Mar 17, 2023

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Feb 15, 2023

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Major Issues Report

8-K - Current report
Feb 03, 2023

Correspondence

CORRESP [Cover] - Correspondence
Feb 03, 2023

Correspondence

CORRESP [Cover] - Correspondence
Feb 03, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Feb 02, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Feb 01, 2023

Correspondence

CORRESP [Cover] - Correspondence